Try Alerts Free   |   Login
Health Care › Services-Commercial Physical And Biological Research

Sorrento Therapeutics (SRNE) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 39 quarters since 2012. Compare with SRNE stock chart to see long term trends.

SRNE Stock Compared to Quarterly

SRNE Income Statement

Revenue, Net:12062000
Revenue Per Share:0.04
Research & Development Expense:49448000
Total Operating Expenses:113449000
Operating Income:-119773000
Income Taxes:386000
Net Income:-119995000
Earnings Per Share, Basic:-0.4
Shares Outstanding, Basic Avg:306335789

SRNE Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:3547000
Net Cash from Operations:-83112000
Net Cash from Financing Activities:40060000
Property, Plant & Equipment Purchases:1175000
Purchases of Businesses, Net of Cash:null
Net Cash from Investing Activities:5396000
Net Change in Cash & Equivalents:-37656000

SRNE Balance Sheet

Cash and Cash Equivalents:39735000
Short-Term Investments:122934000
Accounts Receivable, Net:16454000
Inventories:5427000
Total Current Assets:200720000
Property, Plant & Equipment, Net:45750000
Total Assets:752790000
Accounts Payable:27839000
Current Portion of Long-Term Debt:27486000
Total Short-Term Liabilities:175184000
Long Term Debt, Non-Current Portion:83495000
Total Liabilities:621463000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
20,867,671 sh
1,749,749 sh
9%
$159,218
-$26,035
Vanguard Group Inc
15,506,493 sh
1,376,502 sh
10%
$118,314
-$18,606
State Street Corp
12,287,375 sh
2,054,848 sh
20%
$93,753
-$5,400
Geode Capital Management, LLC
5,059,333 sh
653,387 sh
15%
$38,602
-$4,091
D. E. Shaw & Co., Inc.
2,952,835 sh
1,142,466 sh
63%
$22,530
$4,988
JPMorgan Chase & Co
2,935,011 sh
367,680 sh
14%
$22,395
-$2,482
Northern Trust Corp
2,916,760 sh
61,983 sh
2%
$22,254
-$5,409
Charles Schwab Investment Management Inc
2,032,750 sh
302,190 sh
17%
$15,510
-$1,260
Susquehanna International Group, Llp
Call options for 1,981,400 sh
1,981,400 sh
NEW
$15,118
$15,118
Sabby Management, LLC
1,698,107 sh
500,131 sh
42%
$12,957
$1,349
Bank Of New York Mellon Corp
1,162,385 sh
149,208 sh
15%
$8,869
-$949
Nuveen Asset Management, LLC
1,089,945 sh
-125,802 sh
-10%
$8,992
-$2,788
Wells Fargo & Company/Mn
925,445 sh
98,912 sh
12%
$7,060
-$949
Susquehanna International Group, Llp
Put options for 885,900 sh
885,900 sh
NEW
$6,759
$6,759
Morgan Stanley
861,269 sh
-52,040 sh
-6%
$6,572
-$2,279
Jane Street Group, LLC
Call options for 807,000 sh
807,000 sh
NEW
$6,157
$6,157
Citadel Advisors LLC
Call options for 787,700 sh
787,700 sh
NEW
$6,010
$6,010
Mirae Asset Global Investments Co., Ltd.
786,986 sh
154,327 sh
24%
$6,005
-$125
Schroder Investment Management Group
714,821 sh
-142,476 sh
-17%
$5,454
-$2,854
Susquehanna International Group, Llp
649,089 sh
-288,011 sh
-31%
$4,953
-$4,127

Data imported from Sorrento Therapeutics Inc SEC filings. Check original filings before making any investment decision.